SGMOQOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
SANGAMO THERAPEUTICS, INC
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 14, 2026
$0.10−0.01 (-8.17%)
Close on Oct 19, 2026
- Market cap
- $39.43M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Sangamo Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 14, 2026 | Oct 16, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 17, 2026 | Sep 21, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 2, 2026 | Sep 8, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 25, 2026 | Aug 28, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2026 | Aug 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 14, 2026 | Jul 20, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 24, 2026 | Jul 1, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 18, 2026 | Jun 23, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 14, 2026 | SEC EDGAR |
| Current report | 8-K | May 14, 2026 | May 14, 2026 | SEC EDGAR |
| Annual report, amended | 10-K/A | Dec 31, 2025 | Apr 30, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 28, 2026 | Apr 29, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 30, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 30, 2026 | Mar 30, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 3, 2026 | Feb 4, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 3, 2026 | Feb 3, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 2, 2026 | Feb 3, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 29, 2025 | Oct 29, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 24, 2025 | Sep 30, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 9, 2025 | Sep 11, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 4, 2025 | Sep 4, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 24, 2025 | Jun 24, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 12, 2025 | Jun 16, 2025 | SEC EDGAR |
| Current report | 8-K | May 12, 2025 | May 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 12, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 30, 2025 | May 6, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 12, 2025 | Apr 30, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 17, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 17, 2025 | Mar 17, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 6, 2025 | Feb 6, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 22, 2024 | Dec 30, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 9, 2024 | Dec 10, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 4, 2024 | Oct 4, 2024 | SEC EDGAR |